Zydus Cadila set to bag Kraft Heinz portfolio for Rs 4600 crore, announcement likely on Wednesday

ET on October 11 had reported that Zydus Cadila is the frontrunner for the Kraft Heinz India portfolio. Zydus Cadila is the country ’s fourth-largest Indian pharmaceutical company with Rs 11,600 crore in FY18 sales.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news